Company Filing History:
Years Active: 2013
Title: Warren Hurlburt: Innovator in Cancer Treatment Technologies
Introduction
Warren Hurlburt is a notable inventor based in Mount Laurel, New Jersey, recognized for his contributions to the field of medical innovations. With a focus on advancing cancer treatment methods, Hurlburt has made significant strides in understanding and utilizing biomarkers to enhance therapeutic responses.
Latest Patents
Hurlburt holds a patent titled "Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators." This innovative work involves the use of IGF1R biomarkers to identify and monitor mammals that are likely to respond therapeutically to cancer treatments involving IGF1R modulators. The method encompasses exposing mammals to the modulator and measuring biomarker levels to determine therapeutic effectiveness.
Career Highlights
Warren Hurlburt is employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical firm dedicated to discovering, developing, and delivering innovative medicines. His work within this esteemed institution underscores his commitment to pushing the boundaries of medical knowledge and improving patient outcomes.
Collaborations
Throughout his career, Hurlburt has collaborated with talented colleagues including Fei Huang and Xia Han. These partnerships reflect a collaborative spirit in research that is essential for pioneering breakthroughs in the medical field.
Conclusion
Warren Hurlburt's innovative contributions, particularly in cancer treatment methodologies, highlight his significant role as an inventor. His work with biomarkers not only showcases his expertise but also reinforces the potential for scientific advancements to transform therapeutic practices. As the field of medicine continues to evolve, Hurlburt's inventions may pave the way for more effective cancer treatments in the future.